Until we have peer-reviewed publication of a prospective trial showing superiority of alternatives to vancomycin, its use will continue. The intent of the guidelines was to optimize vancomycin dosing ...
Aims: To analyze the results from the clinical monitoring of serum vancomycin levels among ICU pediatric patients. Methods: A retrospective drug utilization evaluation was performed for pediatric ...
Please provide your email address to receive an email when new articles are posted on . Vancomycin, the only available glycopeptide antibiotic in the United States, continues to be a mainstay of ...
Sandia National Laboratories has created a wearable sensor patch that uses microneedles and nanoscale sensors to continuously monitor the antibiotic vancomycin, offering real-time measurements and ...
Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine ...
ALBUQUERQUE, N.M. (KRQE) – Researchers at Sandia National Laboratories have created a wearable sensor patch capable of continuously monitoring the levels of the antibiotic vancomycin. The lab combined ...
Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...
Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. The bactericidal action of vancomycin results primarily from inhibition of cell-wall ...
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...
COPENHAGEN, Denmark & BUFFALO GROVE, IL.--(BUSINESS WIRE)--Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments, announced today it has ...
Increased use of rapid diagnostic techniques such as PCR may allow prompt discontinuation of vancomycin when not indicated. Further development of alternative antimicrobials may also lessen its use.